Endocrine Society

We are celebrating Internal Medicine Day!  As subspecialty of internal medicine that focuses on the diagnosis and care of disorders of the endocrine system, we want to recognize our Society members who are at the forefront of providing quality care: https://bit.ly/3AguI35  #InternalMedicineDay #IMProud #IMPhysician #endocrinology 

Basic Science Pays Off Watch part two of our "Talking Obesity" video series with Daniel Drucker, MD, to hear more about basic science and its role in discovering GLP-1s for treating people with obesity: https://bit.ly/3NtkeR4  Check out the video and other obesity-related resources on our Focus on Obesity page: https://bit.ly/3yV6Ihc    #JCEM 

Opioids May Negatively Impact Hormone Health A new Scientific Statement released today highlights research gaps associated with the negative effects of opioid use on the endocrine system.  The use and misuse of opioids are a growing global problem. Opioids are used to treat pain in people with cancer or other conditions (e.g., after an injury or surgery), however, they are highly addictive and people can develop opioid use disorder (OUD). The World Health Organization estimates 125,000 people died of opioid overdose in 2019. Read more in Endocrine News: https://bit.ly/3C6O23e “We address the many research gaps associated with the effects and clinical consequences of opioids on the endocrine system within this Scientific Statement. We hope bringing attention to recent research in the space, including opioid use’s impact on gonadal, bone and adrenal conditions, will improve the endocrine health of people using or misusing opioids worldwide.” — Niki Karavitaki, MSc, PhD, FRCP #endocrinology #opiods #opiods #hormonehealth #bonehealth #adrenalhealth #OUD #cancer 

Study Finds Intense Exercise May Suppress Appetite in Healthy Humans  A vigorous workout does more to suppress hunger levels in healthy adults than does moderate exercise, and females may be especially susceptible to this response, according to a small study published in JES: https://bit.ly/3YeBv5r The study examines the effects of exercise intensity on ghrelin levels and appetite between men and women. Ghrelin is known as the “hunger hormone” and is associated with perceptions of hunger.  “We found that high intensity exercise suppressed ghrelin levels more than moderate intensity exercise. In addition, we found that individuals felt ‘less hungry’ after high intensity exercise compared to moderate intensity exercise.” — Kara Anderson, PhD  #JES 

Endocrine News Podcast | Prioritizing Patient Experience in Managing Diabetes  Listen to Rita Rastogi Kalyani, MD, discuss her team’s position statement in JCEM titled, “Prioritizing Patient Experiences in the Management of Diabetes and Its Complications”: https://bit.ly/3ND8BGY  Endocrine.org/podcast             #diabetes #JCEM 

People with Type 2 Diabetes Who Eat Low-Carb May Be Able to Discontinue Medication       Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and possibly discontinue medication, according to new research published in JCEM: https://bit.ly/4eV2wSs    “This study shows people with type 2 diabetes on a low-carbohydrate diet can recover their beta-cells, an outcome that cannot be achieved with medication. People with mild type 2 diabetes who reduce their carbohydrate intake may be able to discontinue medication and enjoy eating meals and snacks that are higher in protein and meet their energy needs.” — Barbara Gower, PhD 

Over the weekend, our Committee on Diversity and Inclusion (CoDI) held a meeting to discuss strategies to develop a more inclusive future. We're proud to foster an environment where diverse voices are not just heard but are instrumental in leading change within the Society and beyond: https://bit.ly/49GUPwY  Our commitment is to develop and support a diverse and inclusive network of clinician, researcher and educator members and leaders who promote health and work to eliminate endocrine health disparities in our local, national, and global communities. CoDI has a committed and dedicated group with a passion for diversity, equity, and inclusion.   We would like to extend a special thank you to our committee for all their care, engagement, commitment, and contributions. Thank you to Drs. Alicia Diaz-Thomas, Nicole Barnes, Trisha Cubb, Patricia Elizalde, Oto-Obong Idah, Jacqueline Maya, Greisha Lee Ortíz-Hernández, Ph.D., Maria Sanchez Valenzuela, Jazma Tapia, and Chinenye Usoh. 

Endocrine Board Review (EBR) 2024 Bundle Is Now Available Our EBR Bundle includes a hard copy of the Endocrine Board Review 16th Edition, access to interactive practice exams, and recordings from our live Q&A session on September 6-8, 2024. This is an indispensable resource for endocrinologists aiming to pass the American Board of Internal Medicine's certification exam. Order now: https://bit.ly/484ZVTh #EBR2024 #endocrinology 

1st International Conference on Steroid Hormones and Receptors (SHR 2024) Is a Wrap!      Our attendees participated in three-days of programing where they explored advances in steroid hormone action related to chemistry, pharmacology, oncology, neurology, metabolism, cardiovascular biology and endocrinology: https://bit.ly/4bzOGn0       “This meeting brought together a broad sampling of cutting-edge nuclear receptor science, scientists, and their mentees in training. The success demonstrates vibrancy in our field. Feedback has been extremely positive for this premier basic science conference. Meetings like this energize the field, bring new and old collaborators together, and stimulate the exchange of new ideas — Carol A. Lange, PhD, Endocrine Society President-Elect     Our attendees have shared the following observations:   ·        “This is the best conference I've ever attended. Everything ran so smoothly. It was just great.” ·        “It’s only the first day and I’ve already learned so much!” ·        “So professional and well done.” ·        “Great conference—everything has been running so smoothly.”    #SHR2024 

Scientific Conference Series Aims to Improve Outcomes for Diabetes, Cancer and Cardiovascular Disease      We will jointly host a series of three conferences to advance endocrine research with Keystone Symposia on Molecular & Cellular Biology. The three conferences will focus on diabetes, oncology and cardiovascular disease—hormone-related conditions that have a major impact on public health     “Each event will feature the top-flight scientific programming and luminary speakers both organizations are known for. The conferences are designed to accelerate scientific breakthroughs, catalyzing advances in foundational science that can ultimately lead to improved clinical outcomes for patients.”       Read more in Endocrine News: https://bit.ly/3NrzQEu     “We are elated about the opportunity to collaborate with Keystone Symposia in the spirit of advancing science. Our basic research members value the opportunity to discuss science with other leading members of the field, and this series of conferences will offer more chances for basic researchers to interact and share ideas.” — John Newell-Price MD, PhD    #diabetes #oncology #cardiovasculardisease #endocrinology